glp-1 long term risks long-term side effects cancer Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Putting Medical Costs on a

Available from: Mafham M, Preiss D

Efficacy and safety of liraglutide and semaglutide on weight loss in people with obesity or overweight: A systematic review

Adjust based on your own schedule and how your body responds throughout the week

Crucially, just as GLP-1s are improving their benefits beyond weight loss, they are also becoming more accessible and inexpensive than ever

The product is available as capsules - 60 per bottle for a 30-day supply at the recommended two capsules daily

And it turns out much of this is not strictly weight loss dependent. In the SELECT cardiovascular outcomes trial published in November 2023, semaglutide was associated with a 20% risk reduction in major adverse cardiovascular events in patients 45 years of age or older compared with placebo